TY - JOUR
T1 - Overexpressed vs mutated Kras in murine fibroblasts
T2 - A molecular phenotyping study
AU - Horsch, M.
AU - Recktenwald, C. V.
AU - Schädler, S.
AU - Hrabé De Angelis, M.
AU - Seliger, B.
AU - Beckers, J.
N1 - Funding Information:
We thank Constanze König and Frank Thiele for their excellent technical support in the qRT–PCR experiments. We are grateful to Rashmi Rajendra for her comments on our manuscript. The work was supported by grants from the National genome research network (NGFN 01GR0448 and 01GR0430) to JB and grants from the Deutsche Forschungsgemeinschaft including the SFB432, A6, DFG581-1/2, and the MERCK KGaA to BS.
PY - 2009/2/24
Y1 - 2009/2/24
N2 - Ras acts in signalling pathways regulating the activity of multiple cellular functions including cell proliferation, differentiation, and apoptosis. Amino-acid exchanges at position 12, 13, or 61 of the Kras gene convert the proto-oncogene into an activated oncogene. Until now, a direct comparison of genome-wide expression profiling studies of Kras overexpression and different Kras mutant forms in a single assay system has not been carried out. In our study, we focused on the direct comparison of global gene expression effects caused by mutations in codon 12 or 13 of the Kras gene and Kras overexpression in murine fibroblasts. We determined Kras cellular mRNA, Ras protein and activated Ras protein levels. Further, we compared our data to the proteome analysis of the same transfected cell lines. Both overexpression and mutations of Kras lead to common altered gene expression patterns. Only two genes, Lox and Col1a1, were reversely regulated in the Kras transfectants. They may contribute to the higher aggressiveness of the Kras codon 12 mutation in tumour progression. The functional annotation of differentially expressed genes revealed a high frequency of proteins involved in tumour growth and angiogenesis. These data further support the important role of these genes in tumour-associated angiogenesis.
AB - Ras acts in signalling pathways regulating the activity of multiple cellular functions including cell proliferation, differentiation, and apoptosis. Amino-acid exchanges at position 12, 13, or 61 of the Kras gene convert the proto-oncogene into an activated oncogene. Until now, a direct comparison of genome-wide expression profiling studies of Kras overexpression and different Kras mutant forms in a single assay system has not been carried out. In our study, we focused on the direct comparison of global gene expression effects caused by mutations in codon 12 or 13 of the Kras gene and Kras overexpression in murine fibroblasts. We determined Kras cellular mRNA, Ras protein and activated Ras protein levels. Further, we compared our data to the proteome analysis of the same transfected cell lines. Both overexpression and mutations of Kras lead to common altered gene expression patterns. Only two genes, Lox and Col1a1, were reversely regulated in the Kras transfectants. They may contribute to the higher aggressiveness of the Kras codon 12 mutation in tumour progression. The functional annotation of differentially expressed genes revealed a high frequency of proteins involved in tumour growth and angiogenesis. These data further support the important role of these genes in tumour-associated angiogenesis.
KW - Gene-expression profiling
KW - Kras mutation
KW - Kras overexpression
KW - Murine fibroblast cell lines
UR - http://www.scopus.com/inward/record.url?scp=60349128616&partnerID=8YFLogxK
U2 - 10.1038/sj.bjc.6604882
DO - 10.1038/sj.bjc.6604882
M3 - Article
C2 - 19190631
AN - SCOPUS:60349128616
SN - 0007-0920
VL - 100
SP - 656
EP - 662
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 4
ER -